BioCentury
ARTICLE | Financial News

Boston Therapeutics amends best efforts offering

May 4, 2015 7:00 AM UTC

Boston Therapeutics Inc. (OTCQB:BTHE), Manchester, N.H. Business: Endocrine/Metabolic, Inflammation, Chemistry Date announced: 2015-04-28 Type: Best efforts offering To be raised: Up to $5 million Sha...